2.4. Sorafenib Treatment Dissociates Beclin 1(BECN1) from MCL1, and the Released BECN1 Inhibits Solute Carrier Family 7 Member 11 (SLC7A11), Culminating in Sorafenib-Triggered Ferroptosis in HCC Cells. Here, SLC17A1 is linked to hepatocellular carcinoma.